← Back to All Stocks

A - Agilent Technologies, Inc.

Technology

Price History

About

Industry

Diagnostics & Research

Employees

18,000

Headquarters

United States


Company Overview

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Price

$113.98

52-Week Range

$96 $160

Dividend Yield

0.91%

Dividend Score

C

Dividend

Yield 0.91%
Annual $1.02
Payout 22%
5Y Avg 0.66%

Valuation

P/E (TTM) 25.2
Fwd P/E 17.3
P/B 4.66
PEG 2.16

Profitability

Profit Margin 18.3%
Op Margin 22.9%
ROE 20.0%
ROA 8.5%

Financial Health

Current Ratio 2.07
Quick Ratio 1.47
Debt/Equity 51%

Cash Flow

Free CF $856M
Op CF $1.4B
Total Cash $1.8B

Analyst Consensus

Buy

16 analysts

Target: $163 $150 - $185
+43.2% implied

Dividend Growth

Most Recent Annual Growth

4.50%

3-Year Avg Growth

-1.67%

5-Year Avg Growth

15.18%

Annual Dividends

Year-over-Year Growth

Recent Dividend History

Ex-Dividend Date Amount
Jan 06, 2026 $0.2550
Sep 30, 2025 $0.2480
Jul 01, 2025 $0.2480
Apr 01, 2025 $0.2480
Dec 31, 2024 $0.2480
Oct 01, 2024 $0.2360
Jul 02, 2024 $0.2360
Apr 01, 2024 $0.2360
Dec 29, 2023 $0.2360
Oct 02, 2023 $0.2250
Jun 30, 2023 $0.2250
Apr 03, 2023 $0.2250
Dec 30, 2022 $0.2250
Oct 03, 2022 $0.2100
Jul 01, 2022 $0.2100
Apr 04, 2022 $0.2100
Jan 03, 2022 $0.2100
Oct 04, 2021 $0.1940
Jul 02, 2021 $0.1940
Apr 05, 2021 $0.1940

Unlock Full Access

Get unlimited access to all features including our powerful dividend screener, detailed stock analysis, and our dividend growth forecasting tool.

Full Screener

300+ proven dividend growth stocks

Growth Forecasts

Project returns with reinvestment

Deep Analysis

Fundamentals & metrics that matter